Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study
Clinical trial NCT04262089 · COMPLETED
Trial details
- NCT number
- NCT04262089
- Sponsor
- University Medical Center Groningen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2023-04-17
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.